Bacterial And Plasmid Vectors Market Report 2026

Bacterial And Plasmid Vectors Market Overview

• Bacteria-based-agricultural-microbials-global-market-report" target="_blank">Bacterial And Plasmid Vectors market size has reached to $0.92 billion in 2025 • Expected to grow to $1.61 billion in 2030 at a compound annual growth rate (CAGR) of 11.9% • Growth Driver: Rising Prevalence Of Cancer And Infectious Diseases Driving Market Growth Due To Increased Demand For Advanced Gene Delivery Technologies • Market Trend: Advancements in Plasmid Vectors for AAV Production • North America was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under Bacterial And Plasmid Vectors Market?

Bacterial and plasmid vectors refer to the means by which recombinant DNA is introduced into a host cell and are essential to molecular cloning. It is a process of creating DNA molecules and introducing them into a host cell. These vectors are used to deliver recombinant DNA into bacteria so they can express proteins. The main types of hosts in bacterial and plasmid vectors are E. coli expression vectors and other bacterial expression vectors. The E. coli expression system enables rapid recombinant protein expression and subsequent large-scale, cost-effective production. For non-glycosylated proteins, this technique is ideal for antigen expression and functional protein expression. The different applications include genetics, molecular biology, bioinformatics, and others and involve various sectors such as hospitals, home care, specialty clinics, and others.

What Is The Bacterial And Plasmid Vectors Market Growth Forecast?

The bacterial and plasmid vectors market size is expected to see rapid growth in the next few years. It will grow to $1.61 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to gene therapy development, growth in biologics production, synthetic biology innovation, increased r&d investments, demand for high-efficiency vectors. Major trends in the forecast period include rising demand for recombinant protein production, growth in gene cloning applications, expansion of synthetic biology research, increasing use in academic research, advancements in vector engineering.

Global Bacterial And Plasmid Vectors Market Segmentation

1) By Host Type: E.Coli Expression Vectors, Other Bacterial Expression Vectors 2) By Application: Genetics, Molecular Biology, Bioinformatics, Other Applications 3) By End Users: Academic And Research Institutes, Biotechnology And Biopharmaceutical Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Industrial And Synthetic Biology Companies, Government And Public Research Laboratories Subsegments: 1) By E. Coli Expression Vectors: PET Vectors, PUC Vectors, PBR322 Vectors, Expression Systems For Protein Production 2) By Other Bacterial Expression Vectors: Bacillus Subtilis Vectors, Pseudomonas Vectors, Lactococcus Lactis Vectors, Streptomyces Vectors

What Is The Driver Of The Bacterial And Plasmid Vectors Market?

Increasing the prevalence of cancer and infectious diseases is anticipated to boost the demand for the bacterial & plasmid vectors market going forward. Bacteria are used as vectors for the delivery of recombinant proteins into target cells for the treatment of cancer and various infectious diseases. The rising prevalence of cancer and infectious diseases is largely due to factors such as increased aging population, lifestyle changes including poor diet and smoking, environmental pollution, and infectious agents. Bacterial and plasmid vectors are utilized in cancer and infectious disease research to deliver therapeutic genes, vaccines, or genetic material that can stimulate immune responses or correct genetic defects, helping to prevent, treat, or manage these diseases by targeting the underlying causes or enhancing the body's defense mechanisms. For instance, in October 2024, according to the World Health Organization, a Switzerland-based health authority, approximately 10.8 million people worldwide contracted tuberculosis, with 55% being men, 33% women, and 12% children and adolescents, and individuals living with human immunodeficiency virus (HIV) representing 6.1% of cases. Therefore, the growing prevalence of cancer and various infectious diseases is driving the growth of the bacterial and plasmid vectors industry.

Key Players In The Global Bacterial And Plasmid Vectors Market

Major companies operating in the bacterial and plasmid vectors market are Sigma-Aldrich Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Promega Corporation, GenScript Biotech Corporation, Takara Bio Inc., New England Biolabs, Agilent Technologies, Bio-Rad Laboratories, ATUM, IBA GmbH, Clontech Laboratories Inc., DNA TwoPointO Inc., Creative Biogene, Creative Biomart, OriGene Technologies Inc., Addgene, Lucigen Corporation, Sino Biological Inc., Oxford Genetics Ltd.

Global Bacterial And Plasmid Vectors Market Trends and Insights

Major companies operating in the bacterial and plasmid vectors market are focusing on developing advanced solutions, such as Innovative Plasmid, to enhance the production of adeno-associated virus (AAV) vectors. An innovative plasmid refers to a plasmid (a small, circular DNA molecule) that has been specially designed or modified to achieve specific, advanced functions in biotechnology, gene therapy, or scientific research. For instance, in March 2024, Polyplus, a France-based biotechnology company, launched the pPLUS AAV-RC2 plasmid, aiming to streamline the manufacturing process and provide a ready-to-use solution that improves both efficiency and reliability in vector production. It offers unique features such as a ready-to-use format optimized for AAV2 production, significant enhancements in viral genome yield when combined with Polyplus transfection reagents, and high-quality manufacturing at a GMP-compliant facility.

What Are Latest Mergers And Acquisitions In The Bacterial And Plasmid Vectors Market?

In August 2024, Merck KGaA, a Germany-based pharmaceutical and life sciences company, acquired Mirus Bio, for an undisclosed amount. Through this acquisition, Merck aims to strengthen its bacterial and plasmid vectors portfolio by integrating Mirus Bio’s innovative non-viral gene delivery technologies and vector platforms, enabling the development of advanced solutions for gene therapy and molecular biology research. Mirus Bio is a US-based biotechnology company, specializes in non-viral vectors and gene delivery systems with a strong track record in preclinical research and biopharmaceutical applications.

Regional Insights

North America was the largest region in the bacterial & plasmid vectors market in 2025. The Middle East is expected to be the fastest-growing region in the global bacterial & plasmid vectors market share during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Bacterial And Plasmid Vectors Market?

The bacterial and plasmid vectors market includes revenues earned by entities by cloning, transferring, and manipulating genes. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bacterial And Plasmid Vectors Market Report 2026?

The bacterial and plasmid vectors market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bacterial and plasmid vectors industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.